June 22, 2026 Oxford BioTherapeutics’ Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3
June 22, 2026 SweetNight Unveils Exclusive CoolNest® Essential Memory Foam Mattress, Delivering Premium Sleep Technology at Exceptional Value on Walmart